Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198238214> ?p ?o ?g. }
- W3198238214 endingPage "2533" @default.
- W3198238214 startingPage "2521" @default.
- W3198238214 abstract "Cisplatin has been reported to promote the expression of programmed cell death ligand-1 (PD-L1) in some cancer cells. However, the underlying mechanism through which PD-L1 is transcriptionally regulated by cisplatin in hepatocellular carcinoma (HCC) cells remains largely unknown. In the present study, we found that the expression of hepatocyte growth factor (HGF), p-Akt, p-ERK, and PD-L1 was increased in cisplatin-treated SNU-368 and SNU-739 cells. HGF stimulation also increased PD-L1 expression in these cells. Moreover, Inhibition of HGF/c-MET, PI3K/Akt, and MEK/ERK signaling pathways can dramatically block cisplatin or HGF-induced PD-L1 expression in SNU-368 and SNU-739 cells. In vivo, combination PHA665752 with cisplatin significantly reduced tumor weight with increased infiltration of CD8+ T cells in the tumor. Taken together, our study suggested that HGF/c-Met axis-induced the activation of PI3K/Akt and MEK/ERK pathways contributes to cisplatin-mediated PD-L1 expression. These findings may provide an alternative avenue for the treatment of HCC." @default.
- W3198238214 created "2021-09-13" @default.
- W3198238214 creator A5000137112 @default.
- W3198238214 creator A5009432724 @default.
- W3198238214 creator A5009577923 @default.
- W3198238214 creator A5016643366 @default.
- W3198238214 creator A5028555668 @default.
- W3198238214 creator A5029594870 @default.
- W3198238214 creator A5039757579 @default.
- W3198238214 creator A5044400781 @default.
- W3198238214 creator A5052175375 @default.
- W3198238214 creator A5067389769 @default.
- W3198238214 creator A5068448731 @default.
- W3198238214 creator A5085108258 @default.
- W3198238214 creator A5085155960 @default.
- W3198238214 creator A5091623169 @default.
- W3198238214 date "2021-09-15" @default.
- W3198238214 modified "2023-09-26" @default.
- W3198238214 title "HGF/c‐MET pathway contributes to cisplatin‐mediated PD‐L1 expression in hepatocellular carcinoma" @default.
- W3198238214 cites W1649526546 @default.
- W3198238214 cites W1799685291 @default.
- W3198238214 cites W1969556504 @default.
- W3198238214 cites W1987281549 @default.
- W3198238214 cites W1988783727 @default.
- W3198238214 cites W2009740683 @default.
- W3198238214 cites W2045459429 @default.
- W3198238214 cites W2050837407 @default.
- W3198238214 cites W2068394692 @default.
- W3198238214 cites W2106418962 @default.
- W3198238214 cites W2161334229 @default.
- W3198238214 cites W2250984169 @default.
- W3198238214 cites W2464944724 @default.
- W3198238214 cites W2613740940 @default.
- W3198238214 cites W2747016053 @default.
- W3198238214 cites W2774523514 @default.
- W3198238214 cites W2888408613 @default.
- W3198238214 cites W2896734282 @default.
- W3198238214 cites W2907787870 @default.
- W3198238214 cites W2942882271 @default.
- W3198238214 cites W2946974661 @default.
- W3198238214 cites W2963606318 @default.
- W3198238214 cites W2965944643 @default.
- W3198238214 cites W2967520916 @default.
- W3198238214 cites W2971172765 @default.
- W3198238214 cites W2982689093 @default.
- W3198238214 cites W2991567947 @default.
- W3198238214 cites W3003480081 @default.
- W3198238214 cites W3046869151 @default.
- W3198238214 cites W3047048186 @default.
- W3198238214 cites W3081630303 @default.
- W3198238214 cites W3091920647 @default.
- W3198238214 cites W3098080011 @default.
- W3198238214 cites W3108110268 @default.
- W3198238214 cites W3114193193 @default.
- W3198238214 cites W3117142916 @default.
- W3198238214 cites W3127991022 @default.
- W3198238214 cites W3128131226 @default.
- W3198238214 cites W3128352598 @default.
- W3198238214 doi "https://doi.org/10.1002/cbin.11697" @default.
- W3198238214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34486197" @default.
- W3198238214 hasPublicationYear "2021" @default.
- W3198238214 type Work @default.
- W3198238214 sameAs 3198238214 @default.
- W3198238214 citedByCount "7" @default.
- W3198238214 countsByYear W31982382142021 @default.
- W3198238214 countsByYear W31982382142022 @default.
- W3198238214 countsByYear W31982382142023 @default.
- W3198238214 crossrefType "journal-article" @default.
- W3198238214 hasAuthorship W3198238214A5000137112 @default.
- W3198238214 hasAuthorship W3198238214A5009432724 @default.
- W3198238214 hasAuthorship W3198238214A5009577923 @default.
- W3198238214 hasAuthorship W3198238214A5016643366 @default.
- W3198238214 hasAuthorship W3198238214A5028555668 @default.
- W3198238214 hasAuthorship W3198238214A5029594870 @default.
- W3198238214 hasAuthorship W3198238214A5039757579 @default.
- W3198238214 hasAuthorship W3198238214A5044400781 @default.
- W3198238214 hasAuthorship W3198238214A5052175375 @default.
- W3198238214 hasAuthorship W3198238214A5067389769 @default.
- W3198238214 hasAuthorship W3198238214A5068448731 @default.
- W3198238214 hasAuthorship W3198238214A5085108258 @default.
- W3198238214 hasAuthorship W3198238214A5085155960 @default.
- W3198238214 hasAuthorship W3198238214A5091623169 @default.
- W3198238214 hasConcept C126322002 @default.
- W3198238214 hasConcept C170493617 @default.
- W3198238214 hasConcept C185592680 @default.
- W3198238214 hasConcept C2776694085 @default.
- W3198238214 hasConcept C2776996007 @default.
- W3198238214 hasConcept C2778239845 @default.
- W3198238214 hasConcept C2780467284 @default.
- W3198238214 hasConcept C502942594 @default.
- W3198238214 hasConcept C55493867 @default.
- W3198238214 hasConcept C57074206 @default.
- W3198238214 hasConcept C62478195 @default.
- W3198238214 hasConcept C71924100 @default.
- W3198238214 hasConcept C75217442 @default.
- W3198238214 hasConcept C86554907 @default.
- W3198238214 hasConceptScore W3198238214C126322002 @default.
- W3198238214 hasConceptScore W3198238214C170493617 @default.